Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Orthomol Med ; 25(1): 29-38, 2010.
Article in English | MEDLINE | ID: mdl-23565030

ABSTRACT

Ascorbic Acid (AA) has been used in the prevention and treatment of cancer with reported effectiveness. Mitochondria may be one of the principal targets of ascorbate's cellular activity and it may play an important role in the development and progression of cancer. Mitochondria, besides generating adenosine triphosphate (ATP), has a role in apoptosis regulation and in the production of regulatory oxidative species that may be relevant in gene expression. At higher concentrations AA may increase ATP production by increasing mitochondrial electron flux, also may induce apoptotic cell death in tumor cell lines, probably via its pro-oxidant action In contrast, at lower concentrations AA displays antioxidant properties that may prevent the activation of oxidant-induced apoptosis. These concentration dependent activities of ascorbate may explain in part the seemingly contradictory results that have been reported previously.

2.
P R Health Sci J ; 25(1): 71-3, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16883681

ABSTRACT

Many mathematical models have been proposed to study tumor growth parameters in vivo. Nevertheless most of the medical models have given variable results even when experimental conditions are exactly the same. There are multiple factors that are capable of affecting tumor growth that should be taken into account when proposing a mathematical model for tumor growth in vivo. We discuss here own proposed model for tumor growth kinetics utilizing a modified Gompertz function that better responds to the growth characteristic of in "vivo" tumors.


Subject(s)
Breast Neoplasms/pathology , Models, Theoretical , Cell Proliferation , Humans , Kinetics
3.
P R Health Sci J ; 24(3): 211-3, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16329685

ABSTRACT

A dietary supplement combination consisting of vitamins, minerals and fibers was studied to determine its safety and efficacy on weight/fat loss, cholesterol and triglycerides in children between ages 7-13. This open label trial measured total body weight, body fat percentage, waist circumference, total cholesterol, triglycerides before and after 6 weeks of treatment. The study population consisted of 25 mildly to moderate obese, otherwise healthy children of both sexes. After 6 weeks of treatment, the combination supplement had a statistically significant (p < 0.05) weight reducing effect. This weight reduction was associated with a corresponding statistically significant (p < 0.0001l) decrease in body fat percentage. In addition, significant decreases in total cholesterol (p < 0.0001) and triglycerides (p < 0.0001) were obtained, plus reductions in waist measurements. We conclude that the combination supplement studied herein is a safe and effective way to assist children in weight, fat percentage, cholesterol and triglyceride reduction.


Subject(s)
Adipose Tissue , Cholesterol/blood , Dietary Supplements , Obesity/blood , Obesity/therapy , Triglycerides/blood , Weight Loss , Adolescent , Child , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...